ATE218165T1 - Phosphatasemodulator - Google Patents

Phosphatasemodulator

Info

Publication number
ATE218165T1
ATE218165T1 AT97908247T AT97908247T ATE218165T1 AT E218165 T1 ATE218165 T1 AT E218165T1 AT 97908247 T AT97908247 T AT 97908247T AT 97908247 T AT97908247 T AT 97908247T AT E218165 T1 ATE218165 T1 AT E218165T1
Authority
AT
Austria
Prior art keywords
pct
erf1
interaction
sec
pp2a
Prior art date
Application number
AT97908247T
Other languages
English (en)
Inventor
Brian Arthur Hemmings
Jozef Prof Goris
Herestraat
Stanislaw Dr Zolnierowicz
Original Assignee
Novartis Erfind Verwalt Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9606707.9A external-priority patent/GB9606707D0/en
Priority claimed from GBGB9626470.0A external-priority patent/GB9626470D0/en
Application filed by Novartis Erfind Verwalt Gmbh filed Critical Novartis Erfind Verwalt Gmbh
Application granted granted Critical
Publication of ATE218165T1 publication Critical patent/ATE218165T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97908247T 1996-03-29 1997-03-17 Phosphatasemodulator ATE218165T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9606707.9A GB9606707D0 (en) 1996-03-29 1996-03-29 Phospatase modulator
GBGB9626470.0A GB9626470D0 (en) 1996-12-20 1996-12-20 The catalytic subunit of protein phosphatase 2A associates with the translation termination factor eRF1
PCT/EP1997/001330 WO1997037037A1 (en) 1996-03-29 1997-03-17 Phosphatase modulator

Publications (1)

Publication Number Publication Date
ATE218165T1 true ATE218165T1 (de) 2002-06-15

Family

ID=26309022

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97908247T ATE218165T1 (de) 1996-03-29 1997-03-17 Phosphatasemodulator

Country Status (7)

Country Link
US (1) US6159704A (de)
EP (1) EP0889971B1 (de)
JP (1) JP4033490B2 (de)
AT (1) ATE218165T1 (de)
AU (1) AU2027997A (de)
DE (1) DE69712878T2 (de)
WO (1) WO1997037037A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6602713B1 (en) 2001-02-09 2003-08-05 Isis Pharmaceuticals, Inc. Antisense modulation of protein phosphatase 2 catalytic subunit beta expression
US6465250B1 (en) 2001-02-09 2002-10-15 Isis Pharmaceuticals, Inc. Antisense modulation of protein phosphatase 2 catalytic subunit alpha expression
US6093544A (en) 1997-05-20 2000-07-25 Cornell Research Foundation, Inc. Rupestris stem pitting associated virus nucleic acids, proteins, and their uses
US6828106B2 (en) * 1999-02-26 2004-12-07 Cyclacel Limited Methods and compositions using coiled binding partners
US6972182B1 (en) * 1999-02-26 2005-12-06 Cyclacel, Ltd. Methods and compositions using coiled binding partners
US6656696B2 (en) * 1999-02-26 2003-12-02 Cyclacel Compositions and methods for monitoring the phosphorylation of natural binding partners
WO2001004629A1 (en) * 1999-07-12 2001-01-18 Mcgill University E4orf4 and pp2a polypeptides, modulators, and mimetics for selectively inducing cell death
FR2827866B1 (fr) * 2001-07-27 2004-12-10 Pasteur Institut Peptides synthetiques ou naturels liant la proteine phosphatase 2a, methode d'identification et utilisations
EP1483283A4 (de) * 2002-03-13 2007-04-11 Signum Biosciences Inc Modulation der proteinmethylierung und phosphoproteinphosphat
CA2601777A1 (en) 2005-02-03 2006-08-10 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
US7923041B2 (en) 2005-02-03 2011-04-12 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180665A (en) * 1990-11-21 1993-01-19 Her Majesty The Queen In Right Of Canada, As Represented By The National Research Council Of Canada Method for quantitatively assaying the presence of diarrhetic shellfish poisoning toxins in marine samples
EP0551200A1 (de) * 1992-01-07 1993-07-14 National University Of Singapore Protein-Phosphatase-Inhibitoren zur Verwendung in der Therapie
AU722840B2 (en) * 1996-03-30 2000-08-10 Medical Research Council Protein phosphatase-1 catalytic subunit interactions
US5914242A (en) * 1996-10-04 1999-06-22 South Alabama Medical Science Foundation Method for diminishing myocardial infarction using protein phosphatase inhibitors
GB9625179D0 (en) * 1996-12-04 1997-01-22 Ver Nl Kanker Inst Phosphatase subunit polypeptide

Also Published As

Publication number Publication date
DE69712878T2 (de) 2002-11-07
US6159704A (en) 2000-12-12
JP2000514642A (ja) 2000-11-07
WO1997037037A1 (en) 1997-10-09
DE69712878D1 (en) 2002-07-04
EP0889971B1 (de) 2002-05-29
AU2027997A (en) 1997-10-22
JP4033490B2 (ja) 2008-01-16
EP0889971A1 (de) 1999-01-13

Similar Documents

Publication Publication Date Title
ATE218165T1 (de) Phosphatasemodulator
DE69831777D1 (de) Framework zur finanziellen Integration von Geschäftsapplikationen
DE69839456D1 (de) System zur Inspektion, Bewertung und Verwaltung von Ausrüstungen
NO20004526D0 (no) Modulatorer for proteintyrosinfosfataser
DE69525408D1 (de) System zur prüfung von nachrichtenübertragungsleitungen
MXPA02001228A (es) Sistema y metodo para determinar requerimientos especificos de documentos de requerimientos generales.
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
AU7301898A (en) Survivin, a protein that inhibits cellular apoptosis, and its modulation
DK0907631T3 (da) Uorganiske ionreceptoraktive forbindelser
DE69626042D1 (de) Verfahren zur anwendung einer beschallungsanlage für grosse räume und eine beschallungsanlage
DE69825856D1 (de) System zur Analyse von Tabellenbildern
AU5530996A (en) System and method of generating prognosis reports for corona ry health management
BR0314380A (pt) Ativação de metaloprotease de miostatina e métodos de modulação da atividade de miostatina
ATE218954T1 (de) Holzschutzmittel für den nachschutz
WO1999019513A3 (en) Methods for detecting compounds which modulate the activity of an lpa receptor
DE69822458D1 (de) Methoden zur umwandlung von flugzeugbremseinheiten
DE59600580D1 (de) Verfahren zur lastmessung
DE50114193D1 (de) Verfahren zur identifizierung von substanzen, die die aktivität von hyperpolarisations-aktivierten kationen-kanälen modulieren
PL329743A1 (en) Method of separating racemic ketanine
WO1999050440A3 (en) Method to identify modulators of survivin - tubulin interaction
ID29545A (id) Perangkat untuk memisahkan bahan-bahan penyusun dari matriks-matriksnya
WO1997040379A3 (en) Assays and reagents for identifying modulators of cdc25-mediated mitotic activation
BR9915263A (pt) Variantes do fator hif-1 "alfa" que induz à hipoxiahumana e métodos para identificação dosmoduladores de hif-1 "alfa"
DE59812587D1 (de) System zur optischen Übertragung von Informationen
ES2186807T3 (es) Inhibidores de trombina.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties